Search results
2 kwi 2024 · Universal vaccination: To reduce community transmission and protect individuals with HIV, this committee agrees with the CDC recommendations for universal vaccination against COVID-19 for adults (≥18 years old) with HIV, regardless of prior history of COVID-19 infection.
22 kwi 2024 · HIV remains a persistent problem in the United States. In the United States, estimated HIV infections decreased 12% overall from 2018 to 2022. Learn more about HIV trends in the United States.
22 lis 2021 · The immunizations section has been updated to reflect the recommendation that all people with HIV should receive a COVID-19 vaccine regardless of their CD4 T lymphocyte count or HIV viral load.
Use this data visualization tool to track our collective progress toward meeting Ending the HIV Epidemic initiative goals. Search the HIV treatment guidelines, HIV drug database, and medical glossary of HIV-related terms. Enter your ZIP code to find HIV testing, PrEP, care and treatment, and other HIV-related services near you.
20 wrz 2023 · A trial of a preventive HIV vaccine candidate has begun enrollment in the United States and South Africa. The Phase 1 trial will evaluate a novel vaccine known as VIR-1388 for its safety and ability to induce an HIV-specific immune response in people.
8 cze 2023 · This includes the recent FDA approval of the drug Apretude, the first injectable treatment option for pre-exposure prevention of HIV, and the continued global commitment to produce a safe and effective vaccine.
1 lut 2022 · Researchers will monitor 56 HIV-negative adults for six months in the Phase 1 clinical trial, typically the first step in a long road to study the safety and efficacy of a vaccine.
